Abstract:Objective Identifying biomarkers of prostatic inflammation has been a question of great interest in the development of anti-inflammatory pharmacotherapy for lower urinary tract symptoms suggestive of benign prostatic hyperplasia (LUTS/BPH). Systemic inflammation and serum prostate-specific antigen (PSA) have been linked with prostatic inflammation. This study set out to develop a diagnostic model for prostatic inflammation using clinical and laboratory parameters. Methods We included LUTS/BPH patients undergoing transurethral resection of the prostate. The severity of prostatic inflammation was determined by pathological review. Clinical manifestations and preoperative laboratory test results were recorded. We used LASSO regression with 10-fold cross-validation to select variables with the most diagnostic value of prostatic inflammation. Furthermore, we used multivariable logistic regression analysis to develop the diagnostic model, presented in a nomogram. The discrimination, calibration of the post-LASSO diagnostic model, and the model supplemented with clinical parameters were assessed. Decision curve analysis was performed. Results A total of 164 patients were included. Of all patients, 97 (59.1%) had no or mild prostatic inflammation, and 67 (40.9%) had moderate to severe prostatic inflammation. A higher peripheral white blood cell count, higher peripheral lymphocyte count, lower free/total (f/t) PSA ratio, and acute urinary retention history were associated with a higher risk of moderate to severe prostatic inflammation. Peripheral lymphocyte count and f/t PSA ratio were selected by the LASSO method and entered into the nomogram. The post-LASSO diagnostic model had an AUC of 0.756 (95% CI: 0.684-0.829) and good calibration. The addition of clinical parameters failed to show incremental diagnostic value. The decision curve analysis demonstrated that the post-LASSO laboratory nomogram was clinically useful. Conclusion Our findings demonstrated that peripheral lymphocyte count and f/t PSA ratio appear to be reliable diagnostic markers, based on which we build a clinically useful nomogram for prostatic inflammation. This diagnostic model could facilitate the development of anti-inflammatory pharmacotherapy for LUTS/BPH. Before this model is adopted in clinical practice, future validation is needed to determine its clinical utility.

A correlation analysis between MRI-derived morphological characteristics of benign prostatic hyperplasia and lower urinary tract symptoms

Relationship Between Lower Urinary Tract Symptoms and Objective Measures of Benign Prostatic Hyperplasia: a Chinese Survey

MRI evaluation of benign prostatic hyperplasia: Correlation with international prostate symptom score

[Transabdominal Ultrasound Measurement of Intravesical Prostatic Protrusion Helps Diagnosis of Benign Prostatic Obstruction].

Prostatic Anatomical Parameters Correlate with Clinical Characteristics Suggestive of Benign Prostatic Hyperplasia

The correlation Study among lower urinary tract symptoms, benign prostatic hyperplasia and erectile dysfunction

Relationship between various clinical factors and LUTS suggestive of benign prostate hyperplasia

Transitional Zone Index and Intravesical Prostatic Protrusion in Benign Prostatic Hyperplasia Patients: Correlations According to Treatment Received and Other Clinical Data.

Periprostatic Fat Thickness Measured on MRI Correlates with Lower Urinary Tract Symptoms, Erectile Function, and Benign Prostatic Hyperplasia Progression

[Correlation of Intravesical Prostatic Protrusion with Clinical Evaluation Parameters in BPH Patients].

Correlation of Prostatic Morphological Parameters and Clinical Progression in Aging Chinese Men with Benign Prostatic Hyperplasia: Results from a Cross-Sectional Study.

The Significance of Transition Zone Volume and Transition Zone Index in the Diagnosis of Benign Prostatic Hyperplasia

A Possible Relationship Between Serum Sex Hormones and Benign Prostatic Hyperplasia/lower Urinary Tract Symptoms in Men Who Underwent Transurethral Prostate Resection

Clinical study the relationship between symptomatic parameters of benign prostate hyperplasia and sexual function

A Retrospective Study: Correlation of Histologic Inflammation in Biopsy Specimens of Chinese Men Undergoing Surgery for Benign Prostatic Hyperplasia with Serum Prostate-Specific Antigen.

Relationship Between Metabolic Syndrome and Predictors for Clinical Benign Prostatic Hyperplasia Progression and International Prostate Symptom Score in Patients with Moderate to Severe Lower Urinary Tract Symptoms.

Presence and severity of lower urinary tract symptoms are inversely correlated with the risk of prostate cancer on prostate biopsy

Correlation between Benign Prostatic Hyperplasia and Metabolic Syndrome

Ultrasonic Measurement of Intravesical Prostatic Protrusion in Benign Prostatic Hyperplasia Patients

[Clinical Significance of Prostatic-Specific Antigen Levels in Patients with Benign Prostatic Hyperplasia Complicated by Low Urinary Tract Syndrome].

Detection of Prostatic Inflammation From Peripheral Lymphocyte Count and Free/Total PSA Ratio in Men With LUTS/BPH.